What they do
Bloom Burton & Co. is a Toronto healthcare-focused investment bank that raises capital, advises on M&A and strategy, and provides equity research and sales and trading for healthcare companies and investors.
- Services
- Private capital raising, Equity raisings, Buy-side M&A, Sell-side M&A, Takeovers and schemes, Independent expert reports, Valuations
- Specialties
- healthcare, biotechnology, pharmaceuticals, medical devices, diagnostics, healthcare services, healthcare IT, animal health
- Deal size
- Recorded deals: median A$653m
- Clients
- Investors and funds
- Memberships
- CIRO, CIPF
From bloomburton.com, checked 7 Nov 2026: /, /service/mergers-and-acquisition-advisory/
Deals
Columns
1 of 1 deals
| Advisers | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 2026 | PYC Therapeutics | – | – | Entitlement offer | Lead manager and joint lead manager | Completed | 653.0 | Biotech and pharmaceuticals | E&P Capital (lead manager)Barrenjoey (lead manager)Herbert Smith Freehills Kramer (issuer) | PYC Therapeutics entitlement offer |
Listed on their website
- Nualtis Corp. M&A Advisory US $15,000,000 · 2026
- Apotex Health Corp. Bought Deal Secondary Offering C $850,000,000 · 2026
- BetterLife Pharma Public Offering US $100,000,000 · 2026
- Conavi Medical Corp. Public Offering CDN $10,000,000 · 2026
- Andone Pharmaceuticals Inc. M&A Advisory 2026
- Helus Pharma Underwritten Offering US $50,000,000 · 2026
- Apotex Health Corp. Initial Public Offering CDN$1, 495,000,080 · 2026
- FORUS Therapeutics M&A Advisory US $36,500,000 · 2026
- Thiogenesis Therapeutics Non-brokered Private Placement CDN $9,070,000 · 2026
- Medicenna Therapeutics Corp. Public Offering CDN $4,440,000 · 2026
- PharmaSystems Inc. M&A Advisory CDN $13,500,000 · 2026
- Crescita Therapeutics Fairness Opinion 2026
Transactions the firm lists on its own website, checked 7 Nov 2026. Those FundComb has recorded link to the deal.
Offices and contact
Offices
- TorontoHead office